Watanabe T, Matsuura M, Seto K
J Clin Microbiol. 1986 Jun;23(6):1034-8. doi: 10.1128/jcm.23.6.1034-1038.1986.
Saliva samples collected from 393 subjects with and without oral diseases were examined for concentrations of mycoplasmas and Mycoplasma species. Mycoplasmas were isolated from 383 (97%) of the 393 subjects. Viable counts ranged from zero to 7.6 X 10(7) CFU/ml (median, 6.9 X 10(4)) and were significantly (P less than 0.01) higher in diseased subjects, except for those with arthrosis temporomandibularis, than in controls. Of 1,400 isolates, 897 (64%), 442 (30%), and 8 (1%) were identified as Mycoplasma salivarium, M. orale, and M. hominis, respectively, and the remaining 73 isolates (5%) were unidentifiable. More than two-thirds of the isolates from diseased subjects versus only half from controls were identified as M. salivarium. In diseased subjects other than those with ostitis (especially those with arthrosis temporomandibularis), the incidence of M. salivarium was higher than that of M. orale, whereas the former occurred about as frequently as the latter in the controls. Antibodies to M. salivarium were also measured in sera from some subjects by the metabolism inhibition test. Sera with metabolism inhibition titers of 16 or greater were rated positive. There was no significant difference in the prevalence of antibodies between diseased subjects (60%) and controls (40%), but the mean titers (97 to 220) of all positive sera from diseased subjects were two to four times those for sera from controls. In addition, a fourfold or greater rise or fall of antibody titers to the organism was shown in paired sera from some subjects. On the basis of these results, M. salivarium was strongly suggested to participate etiologically in some cases of oral infection.
对393名有或无口腔疾病的受试者采集唾液样本,检测支原体和支原体种类的浓度。在393名受试者中,有383名(97%)分离出了支原体。活菌计数范围为零至7.6×10⁷CFU/ml(中位数为6.9×10⁴),除颞下颌关节病患者外,患病受试者的活菌计数显著高于对照组(P<0.01)。在1400株分离株中,分别有897株(64%)、442株(30%)和8株(1%)被鉴定为唾液支原体、口腔支原体和人型支原体,其余73株(5%)无法鉴定。患病受试者中超过三分之二的分离株被鉴定为唾液支原体,而对照组中只有一半。在除骨炎患者(尤其是颞下颌关节病患者)以外的患病受试者中,唾液支原体的发生率高于口腔支原体,而在对照组中两者发生率大致相同。还通过代谢抑制试验检测了部分受试者血清中针对唾液支原体的抗体。代谢抑制效价为16或更高的血清被评定为阳性。患病受试者(60%)和对照组(40%)之间抗体流行率无显著差异,但患病受试者所有阳性血清的平均效价(97至220)是对照组血清的两至四倍。此外,部分受试者配对血清中针对该病原体的抗体效价有四倍或更高的升高或降低。基于这些结果,强烈提示唾液支原体在某些口腔感染病例中具有病因学作用。